| (11) | Number of the document | 4581 |
| (21) | Number of the application | a 2017 0084 |
| (22) | Filing date of the application | 2017.10.06 |
| | Date of filing the request for examination | (de fond) 06.10.2017 |
| (71) | Name(s) of applicant(s), code of the country | UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (72) | Name(s) of inventor(s), code of the country | GULEA Aurelian, MD; GRAUR Vasilii, MD; TAPCOV Victor, MD; |
| (73) | Name(s) of owner(s), code of the country | UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (54) | Title of the invention | 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | C07C 337/08 (2006.01); C07D 213/48 (2006.01); A61K 31/175 (2006.01); A61P 35/02 (2006.01); |
| (19) | Country | MD |
| (45) | Date of publication of patent granting decision: | 2018.07.31 |
| (47) | Date of issuance of patent | 2019.02.28 |
| | Substantive examiner(s) | GROSU Petru |
| | Payment for maintenance up to the date | 2022.10.06 |
| | Date of patent termination | 2022.10.06 |
| | Date of publication of the termination of patent, with the right of restoration | 2023.06.30 |
| | Date of publication of the termination of patent, without the right of restoration | 2024.08.31 |